Identification of Antibiotic Resistance of Acinetobacter baumannii in Iraqi Patients

Maha E. Zidan; Jaleel Samanje; Hiba Mansour  Nasir

doi:10.51173/jt.v4i33.589

Authors

Maha E. Zidan College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, Iraq
Jaleel Samanje College of Health and Medical Techniques, Middle Technical University (MTU), Baghdad, Iraq
Hiba Mansour Nasir College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, Iraq

DOI:

https://doi.org/10.51173/jt.v4i33.589

Keywords:

A. baumannii, Amikacin, MDR, Meropenem, Sputum

Abstract

A. baumannii is an opportunistic pathogen that was once regarded as a low-category pathogen but is now a prominent source of hospital and community-acquired illnesses. It is a prevalent cause of pneumonia. To investigate the prevalence of antibiotics resistance among A baumannii.

Two-hundred clinical smaples were collected including (burns, sputum, urine and wound swabs) from individuals suffering from different complaints such as surgical and wound infections, burns inflammation, inflammation of the urinary tract, pneumonia and COVID-19 patients. 86 A. baumannii bacterial isolates could be picked up from these samples using routine test and VITEK-2 system. After diagnosis the A baumannii strains were subjected to an antibiotic sensitivity test using Kirby-Bauer disk diffusion method against Seven type of antibiotics.

A baumannii isolates a exhibited high resistance rate under the effect of tetracycline, Ciprofloxacin, Meropenem and Amikacin antibiotics (92%,76, 72%,72%) respectively. Multidrug resistance profile of 86 A baumannii isolates were 47.6% DR, 37.6% XDR and 15.1 MDR. A significant difference was noticed between the susceptibility profile of 86 A. baumannii isolates at (F.S.P. 50.5, p-value= 0.001).

Reduced susceptibility or resistance to carbapenems is increasingly being observed in A. baumannii clinical isolates, which is an opportunistic bacterium associated with serious hospital infections.

Downloads

Download data is not yet available.

References

J. F. Turton, M. E. Kaufmann, M. J. Gill, R. Pike, P. T. Scott, J. Fishbain, et al., "Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict," Journal of clinical microbiology, vol. 44, pp. 2630-2634, 2006.

Wallace L, Daugherty SC, Nagaraj S, Johnson JK, Harris AD, Rasko DA. "Use of comparative genomics to characterize the diversity of Acinetobacter baumannii surveillance isolates in a health care institution". Antimicrobial agents and chemotherapy, vol. 60(10), pp.5933-41, 2016.

H. W. Boucher, G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert, L. B. Rice, et al., "Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America," Clinical infectious diseases, vol. 48, pp. 1-12, 2009.

R. Rada, R. Nakhli, S. Khayati, L. A. Said, and K. Zahlane, "Epidemiological Aspect and Antibiotic Resistance Profile of Acinetobacter baumannii in the Resuscitation Department of Ibn Tofail Hospital CHU Med V," Haya Saudi J Life Sci, vol. 7, pp. 74-77, 2022.

J. Blair, M. A. Webber, A. J. Baylay, D. O. Ogbolu, and L. J. Piddock, "Molecular mechanisms of antibiotic resistance," Nature reviews microbiology, vol. 13, pp. 42-51, 2015.

I. Kyriakidis, E. Vasileiou, Z. D. Pana, and A. Tragiannidis, "Acinetobacter baumannii antibiotic resistance mechanisms," Pathogens, vol. 10, p. 373, 2021.

L. W. Roberts, B. M. Forde, T. Hurst, W. Ling, G. R. Nimmo, H. Bergh, et al., "Genomic surveillance, characterisation and intervention of a carbapenem-resistant Acinetobacter baumannii outbreak in critical care," medRxiv, 2020.

P. Schober, C. Boer, and L. A. Schwarte, "Correlation coefficients: appropriate use and interpretation," Anesthesia & Analgesia, vol. 126, pp. 1763-1768, 2018.

Z. A. Kanafani, N. Zahreddine, R. Tayyar, J. Sfeir, G. F. Araj, G. M. Matar, et al., "Multi-drug resistant Acinetobacter species: a seven-year experience from a tertiary care center in Lebanon," Antimicrobial Resistance & Infection Control, vol. 7, pp. 1-8, 2018.

P. Visca, H. Seifert, and K. J. Towner, "Acinetobacter infection–an emerging threat to human health," IUBMB life, vol. 63, pp. 1048-1054, 2011.

S. Kadam, S. Shai, A. Shahane, and K. S. Kaushik, "Recent advances in non-conventional antimicrobial approaches for chronic wound biofilms: have we found the ‘chink in the armor’?," Biomedicines, vol. 7, p. 35, 2019.

B. Lukovic, I. Gajic, I. Dimkic, D. Kekic, S. Zornic, T. Pozder, et al., "The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates," Antimicrobial Resistance & Infection Control, vol. 9, pp. 1-12, 2020.

N. Zahra, B. Zeshan, M. M. A. Qadri, M. Ishaq, M. Afzal, and N. Ahmed, "Phenotypic and genotypic evaluation of antibiotic resistance of Acinetobacter baumannii bacteria isolated from surgical intensive care unit patients in Pakistan," Jundishapur Journal of Microbiology, vol. 14, 2021.

W. A. H. Al-Daraghi and S. A. Al-Taliby, "Study the Incidence of Acinetobacter Baumannii as a Nosocomial Pathogen," Indian Journal of Public Health Research & Development, vol. 10, 2019.

Z. Rahimi, Y. Malekzadegan, A. Bahador, M. Azimzadeh, and M. A. Haghighi, "Phylogenetic study, distribution of virulence genes and antibiotic resistance profiles of Escherichia coli isolated from Bushehr coastal water," Gene Reports, vol. 26, p. 101473, 2022.

M. S. van den Honert, P. A. Gouws, and L. C. Hoffman, "A Preliminary Study: Antibiotic Resistance of Escherichia coli and Staphylococcus aureus from the Meat and Feces of Various South African Wildlife Species," Food Science of Animal Resources, vol. 41, p. 135, 2021.

A. Ponce-de-Leon, E. Rodríguez-Noriega, R. Morfín-Otero, D. P. Cornejo-Juárez, J. C. Tinoco, A. Martínez-Gamboa, et al., "Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)," PLoS One, vol. 13, p. e0198621, 2018.

M. Q. Alanazi, M. I. Al-Jeraisy, and M. Salam, "Prevalence and predictors of antibiotic prescription errors in an emergency department, Central Saudi Arabia," Drug, healthcare and patient safety, vol. 7, p. 103, 2015.

G. K. McEvoy, AHFS drug information, 2000: American society of health-system pharmacists, 2000.

H. Bijie, S. Kulpradist, M. Manalaysay, and A. Soebandrio, "In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins," Journal of chemotherapy (Florence, Italy), vol. 17, pp. 3-24, 2005.

B. Mirzaei, Z. N. Bazgir, H. R. Goli, F. Iranpour, F. Mohammadi, and R. Babaei, "Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran," BMC research notes, vol. 13, pp. 1-6, 2020.